2018 CPIP-L Case 12: Coagulation – Direct Oral Anticoagulant (DOAC) Medications: Impact on Routine and Specialized Laboratory Coagulation Testing - CPIP1212Q.2018
Untitled Document


Learn the types of direct oral anticoagulants (DOACs), their effects on laboratory testing, and suitable methods to effectively communicate drug interferences to medical providers ordering coagulation tests.

Credit Type: CME, SAM, CPD
Duration: 1 hour 15 minutes
Launch Date: December 17, 2018
Expiration Date: December 16, 2021 12:00 AM (ET)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge, Patient Care

Registration Information
THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.

To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, contact the CAP at 800-323-4040 option 1. This option is only available until December 31, 2018, after this date this activity is only accessible by an online credit card payment.

Description
Direct oral anticoagulation (DOAC) medications are beginning to replace traditional oral vitamin K antagonist medications; therefore, it is necessary to understand how these medications can impact coagulation assay results. Learn how to proactively communicate specific information outlining the impact of DOAC medications on coagulation testing and how to prevent misinterpretation of results which may lead to inaccurate diagnoses and treatment decisions.

This clinical pathology activity is intended for pathologists and residents.

Objectives
After completing this SAM eligible activity and post-test, you should be able to:

  1. Recognize the name and mechanisms of the direct oral anticoagulant (DOAC) medications used for the treatment/prevention of venous thrombosis.
  2. Explain how DOAC medications impact routine and specialized coagulation assays, including clot-based and chromogenic methods.
  3. Identify communication modalities to educate clinical medical providers regarding the impact of DOAC medications on coagulation testing.

Related Link
Clinical Pathology Improvement Program

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Pathology’s (ABP) Continuing Certification (CC), formerly known as Maintenance of Certification (MOC), requirements for Self-Assessment Modules (SAMs).

Continuing Professional Development (CPD), Section 3 Credit
Accreditation in Canada: This event is an Accredited Self Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by the Canadian Association of Pathologists - Association Canadienne des Pathologistes. You may claim a maximum of 1.25 hours equivalent to 3.75 credits.

Passing Requirements
You have a total of three opportunities to take and pass the post-test. If you correctly answer 70% or more of the post-test items, you may claim credit. CME/SAM credit can be applied to the American Board of Pathology (ABP) Self-Assessment Module (SAM) requirements. You must pass the post-test to claim credit; therefore, if you do not pass, you cannot claim any credit.

Attention Canadian Participants: You have three opportunities to take and pass the post-test. If you do not pass the post-test after three attempts, you may still claim CPD credit (self-assessment program credits) for this activity. Please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or education@cap.org with the name of this activity and the date completed to request a letter of participation.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
Education Division
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847 832-8006.

Technical Requirements
Pop-up blockers must be turned off.

CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800 323-4040 option 1 or education@cap.org.

Availability
This activity and evaluation is available December 17, 2018, and will expire on December 16, 2021, at 12:00 AM (ET). You MUST claim credit by this date and time.

CC: CPIP1212Q.2018






Non-Member Price:   $59.00  
 
Member Price:  $45.00   


2018 CPIP-L Case 12: Coagulation – Direct Oral Anticoagulant (DOAC) Medications: Impact on Routine and Specialized Laboratory Coagulation Testing